Premature ventricular contraction-induced cardiomyopathy: an emerging entity

Cao Thach Tran, Hugh Calkins

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Introduction: Over the past 10–15 years, there has been an increasing amount of evidence that frequent premature ventricular contractions (PVCs) are associated with the development of a reversible cardiomyopathy. Areas covered: This review considers current evidence of the association between PVCs and the development of cardiomyopathy, risk factors, and available treatment modalities based on available published literature. Expert commentary: The field is rapidly evolving, although evidence is based primarily on observational studies. Pharmacological therapy may suppress PVCs and lead to resolution of cardiomyopathy in many patients. In addition, catheter ablation has emerged as an effective treatment modality that has compared favorably to pharmacological antiarrhythmic therapy. The excellent outcome in successfully treated patients should prompt physicians to consider whether frequent PVCs may be a contributing factor in patients with heart failure.

Original languageEnglish (US)
Pages (from-to)1227-1234
Number of pages8
JournalExpert Review of Cardiovascular Therapy
Issue number11
StatePublished - Nov 1 2016


  • cardiomyopathy
  • catheter ablation
  • outflow tract arrhythmia
  • premature ventricular complexes
  • Premature ventricular contractions
  • ventricular arrhythmia

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Premature ventricular contraction-induced cardiomyopathy: an emerging entity'. Together they form a unique fingerprint.

Cite this